Weaver Consulting Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Weaver Consulting Group's AMGN Position: Q3 2026 in Review
Weaver Consulting Group increased its Amgen (AMGN) stake by 3.9% in Q3 2026, buying an estimated $25.1K and bringing the position to 1,696 shares worth $715K. The position accounts for 0.14% of the portfolio, ranked #133.
Weaver Consulting Group first reported a position in AMGN in Q1 2019 and has held it in 31 quarters since. 1,057 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Weaver Consulting Group held 1,696 shares of Amgen worth $715K as of Q3 2026.
- Weaver Consulting Group bought 63 Amgen shares in Q3 2026, an estimated $25.1K.
- Amgen made up 0.14% of Weaver Consulting Group's portfolio in Q3 2026, its #133 holding.
- Weaver Consulting Group first reported a position in Amgen in Q1 2019 and has held it in 31 quarters since.
- 1,057 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Weaver Consulting Group's 13F filing for Q3 2026, filed 7 Oct 2026.